Abstract
This report extends the knowledge on the epizootical situation of foot-and-mouth disease in Asia. RNA from six samples of type A and five of type O virus, isolated between 1987 and 1997 in Bangladesh, Iran, Malaysia and Turkey, was subjected to reverse transcription-dependent polymerase chain reactions that amplify large parts of the capsid protein VP1 encoding genome region. The amplification products were sequenced, and the sequences aligned to each other and to published sequences. This showed the type O isolates of 1987–1997 from Bangladesh to be of same genotype and closely related to isolates of 1988 and later from Saudi Arabia, 1990 from India, 1996 from Greece and Bulgaria, and 1997 from Iran. Among the analyzed type A isolates, those of 1992 and 1996 from Turkey were of same genotype and related to previously described isolates of 1987 from Iran and of 1992 from Saudi Arabia. The isolate of 1997 from Malaysia was found to be related to isolates from Thailand of 1993 and 1996. The isolates of 1987 from Bangladesh and 1997 from Iran, however, represent different so far not described genotypes. Monoclonal antibodies, raised against the vaccine production strains A22 Iraq, Asia1 Shamir, O1 Kaufbeuren and O1 Manisa, and the recent type A field isolates Saudi Arabia/92 and Albania/96, were used in an ELISA to compare the reaction patterns of many of the field isolates. The monoclonal antibodies were further characterized for virus-neutralizing activity and binding to trypsinized homologous virus. The failure of neutralizing antibodies in binding to trypsinized homologous as well as to heterologous virus suggested the epitopes to reside at the major antigenic component of the virus, which is the capsid protein VP1. Two non-neutralizing antibodies that bind to trypsin-sensitive epitopes cross-reacted, however, with heterologous virus. This indicates the existence of a trypsin-sensitive antigenic site outside of VP1. In summary, the results obtained by ELISA confirm the observed sequence differences, but indicate further sequence differences at minor antigenic sites that do not reside on VP1.
Similar content being viewed by others
References
Palmenberg A.C., in Molecular Aspects of Picornavirus Infection and Detection. (eds Semler B.L. and Ehrenfeld E.) American Society for Microbiology,Washington, DC, pp. 211± 241, 1989.
MartiÂnez M.A., Dopazo J., HernaÂndez J., Mateu M.G., Sobrino F., Domingo E., and Knowles N.J., J Virol 66, 3557±3365, 1992.
Domingo E., Escarmis C., MartiÂnez M.A., MartiÂnez-Salas E., and Mateu M.G., Curr Top Microbiol Immunol 176, 33±47, 1992.
Sobrino F., Palma E.L., Beck E., DaÂvila M., de la Torre J.C., Negro P., Villanueva N., Ortin J., and Domingo E., Gene 50, 149±159, 1986.
Gebauer F., de la Torre J.C., Gomes I., Mateu M.G., Barahona Molecular Analysis of Recent FMDV Field Isolates 181 H., Tiraboschi B., Bergmann I., Auge de Mello P., and Domingo E., J Virol 62, 2041±2049, 1988.
Knowles N.J., Marquardt O., and Samuels A.R., Report to the Session of the Research Group of the Standing Technical Committee of the EC for the Control of FMDV, Prague, 1988.
Krebs O., Ahl R., Straub O.C., and Marquardt O., Vaccine 11, 359±362, 1993.
Acharya R., Fry E., Stuart D., Fox G., Rowlands D., and Brown F., Nature 337, 709±716, 1989.
Brown F., Semin Virol 6, 243±248, 1995.
VoslooW., Knowles N.J., and Thomson G.R., Epidemiol Infect 109, 547±558, 1992.
Kitching R.P., J Comp Path 118, 89±118, 1998.
Kramer M., Jentsch D., Kaden V., SchluÈter H., and Zwingmann D., AmtstieraÈztl Dienst u Lebensmittelktrl 4, 196±202, 1997.
Marquardt O. and Haas B., Virus Genes 16, 185±193, 1998.
Marquardt O. and Adam K.-H., Virus Genes 2, 283±291, 1988.
Armstrong R.M., Samuel A.R., Carpenter W.C., Rama Kant, and Knowles N.J., Vet Microbiol 39, 285±298, 1994.
Samuel A.R., Knowles N.J., Kitching R.P., and Hafez S.M., Epidemiol Infect 119, 381±389, 1997.
Singh M., Mohan B.M., and Suryanarayana V.V.S., Virus Res 43, 45±55, 1996.
Suryanarayana V., Tulasiram P., Prabhudas K.S., Misra L.D., and Natarajan C., Virus Genes 16, 167±172, 1998.
Pfaff E., Thiel H.-J., Beck E., Strohmaier K., and Schaller H., J Virol 62, 2033±2040, 1988.
Pfaff E., MuÈ ller H., Haas B., and Thiel H.-J., in Vaccines 89. (eds. Lerner R.A., Ginsberg H., Chanock R.M., and Brown F.) Cold Spring Harbor Laboratory, pp. 449±455, 1989.
Strohmaier K., Franze R., and Adam K.-H., J Gen Virol 59, 295±306, 1982.
Forss S., Strebel K., Beck E., and Schaller H., Nucl Acids Res 12, 6581±6601, 1984.
Bahnemann H.G., Vaccine 8, 299±303, 1990.
Shulman M., Wilde C.D., and KoÈhler G., Nature 267, 269±270, 1978.
Galfre G. and Milstein C., Meth Enzymol 73, 3±46, 1981.
Bazin R. and Lemieux R., J Immunol Meth 116, 245±249, 1989.
Hawkes K., Niday E., and Gordon J., Anal Biochem 119, 142± 147, 1982.
Roeder L.P. and Le Blanc Smith P.M., Res Vet Sci 43, 225±232, 1987.
Kitching R.P., Rendle R., and Ferris N.P., Vaccine 6, 403±408, 1988.
Bastos A.D., Onderstepoort J Vet Res 65, 37±47, 1998.
Fox G., Parry N.R., Barnett P.V., McGinn B., Rowlands D., and Brown F., J Gen Virol 70, 625±637, 1989.
Bachrach H.L., Annu Rev Microbiol 22, 201±244, 1968.
King A.M.Q., Underwood B.O., McCahon D., Newman J.W.I., and Brown F., Nature 293, 479±480, 1981.
McCullough K.C., De Simone F., Brocchi E., Capucci L., Crowther J.R., and Khim U., J Gen Virol 66, 1835±1840, 1992.
Barteling S.J. and Vreeswijk J., Vaccine 9, 75±88, 1991.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Freiberg, B., Rahman, M.M. & Marquardt, O. Genetical and Immunological Analysis of Recent Asian Type A and O Foot-and-Mouth Disease Virus Isolates. Virus Genes 19, 167–182 (1999). https://doi.org/10.1023/A:1008183312319
Issue Date:
DOI: https://doi.org/10.1023/A:1008183312319